Skip to content
Screener

MBX Biosciences, Inc. MBX Q2 2025 earnings

Reported August 7, 2025 · Before market open

EPS-$0.58Beat by $0.19
EPS estimate-$0.77

Next report

Nov 5, 2026 (in 3 months)
EPS estimate-$0.74

Financials

Q2 2025

Income statement

See full
Operating income-$21.8M-30.9%
Net income-$19.4M-22.4%
EPS (diluted)-$0.58+95.4%

Balance sheet

See full
Cash & equivalents$39.8M—
Total debt$650.0K—
Total equity$219.2M+324%
Total assets$231.5M—

Cash flow

See full
Operating cash flow-$17.4M-31.4%
CapEx$707.0K+56.4%
Free cash flow-$18.1M-32.2%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$369.34M—
Enterprise value$330.21M—

Returns & leverage

See full
Debt / equity0×—
Current ratio19.5×—

FAQ

When did MBX Biosciences, Inc. report Q2 2025 earnings?
MBX Biosciences, Inc. (MBX) reported Q2 2025 earnings on August 7, 2025 before market open.
What were MBX Biosciences, Inc.'s Q2 2025 revenue and EPS?
MBX Biosciences, Inc. reported eps of $-0.58 for Q2 2025.
Did MBX Biosciences, Inc. beat estimates in Q2 2025?
EPS beat the consensus estimate of $-0.77 by $0.19.
Where can I find MBX Biosciences, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-104602) and the 10-Q periodic report (0000950170-25-104619) directly on SEC EDGAR. The filing index links above go to sec.gov.